The ESCMID Study Group for Viral Hepatitis (ESGVH) is deeply committed to advancing knowledge on viral hepatitis. Uniting members from all over the globe, they are dedicated to:
ESGVH Newsletter, Spring 2024, May 2024
ESGVH Newsletter, Spring 2024, April 2024
ESGVH Newsletter, Winter 2023, February 2023
ESGVH Newsletter, Spring 2023, May 2023
ESGVH Newsletter, Summer 2023, July 2023
ESGVH Newsletter, Autumn 2023, October 2023
ESGVH Newsletter, Winter 2023, December 2023
Exposure to biological fluids in dental practice – Narrative review on appropriate risk assessment to guide post-exposure management.
Săndulescu M, Nicolescu MI, Funieru C, Şahin GÖ, Săndulescu O and ESCMID Study Group for Viral Hepatitis (ESGVH). Pathogens. 2023;12(7):968.
COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes.
Said ZNA, El Habashy SA, Zaky S and ESCMID Study Group for Viral Hepatitis (ESGVH). World J Gastroenterol. 2023;29(7):1123–1130.
Breaking the Wall on Hepatitis A and E Vaccination: Should we change current recommendations?
18 December 2023
If you have questions or comments for our study group, we warmly invite you to contact us!